Early‐Life Infections, Antibiotics and Later Risk of Childhood and Early Adult‐Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2024-10-25 DOI:10.1111/apt.18358
Karl Mårild, Tereza Lerchova, Malin Östensson, Henrik Imberg, Ketil Størdal, Johnny Ludvigsson
{"title":"Early‐Life Infections, Antibiotics and Later Risk of Childhood and Early Adult‐Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts","authors":"Karl Mårild, Tereza Lerchova, Malin Östensson, Henrik Imberg, Ketil Størdal, Johnny Ludvigsson","doi":"10.1111/apt.18358","DOIUrl":null,"url":null,"abstract":"BackgroundChildhood antibiotic use has been associated with inflammatory bowel disease (IBD), although the potential contribution of infection frequency remains uncertain.AimsTo explore the association between early‐life infections, antibiotics and IBD development.MethodsWe used population‐based data from ABIS (Sweden) and MoBa (Norway) cohorts following children from birth (1997–2009) until 2021. Prospectively collected questionnaires identified infection frequency (any, gastrointestinal and respiratory) and antibiotics (any, penicillin and non‐penicillin) until age 3. IBD diagnosis required ≥ 2 records in national health registries. Cohort‐specific hazard ratios (aHR), adjusted for parental education, smoking and IBD were estimated and pooled using a random‐effects model. Antibiotic analyses were adjusted for infection frequency.ResultsThere were 103,046 children (11,872 ABIS and 91,174 MoBa), contributing to 1,663,898 person‐years of follow‐up, during which 395 were diagnosed with IBD. The frequency of any infection at 0 to < 1 and 1 to < 3 years showed a pooled aHR of 1.01 (95% confidence interval [CI] = 0.96–1.07) and 1.00 (95% CI = 0.99–1.01) per additional infection for IBD. Adjusting for infections, any versus no antibiotics in the first year was associated with IBD (pooled aHR = 1.33 [95% CI = 1.01–1.76]). The aHR for additional antibiotic course was 1.17 (95% CI = 0.96–1.44), driven by penicillin (per additional course, aHR = 1.28 [95% CI = 1.02–1.60]). Although antibiotics at 1 to < 3 years did not show an association with IBD or Crohn's disease, non‐penicillin antibiotics were associated with ulcerative colitis (per additional course, aHR = 1.95 [95% CI = 1.38–2.75]).ConclusionEarly‐life antibiotic use was, a significant risk factor for childhood and early adult‐onset IBD, independent of infection frequency.","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"96 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apt.18358","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundChildhood antibiotic use has been associated with inflammatory bowel disease (IBD), although the potential contribution of infection frequency remains uncertain.AimsTo explore the association between early‐life infections, antibiotics and IBD development.MethodsWe used population‐based data from ABIS (Sweden) and MoBa (Norway) cohorts following children from birth (1997–2009) until 2021. Prospectively collected questionnaires identified infection frequency (any, gastrointestinal and respiratory) and antibiotics (any, penicillin and non‐penicillin) until age 3. IBD diagnosis required ≥ 2 records in national health registries. Cohort‐specific hazard ratios (aHR), adjusted for parental education, smoking and IBD were estimated and pooled using a random‐effects model. Antibiotic analyses were adjusted for infection frequency.ResultsThere were 103,046 children (11,872 ABIS and 91,174 MoBa), contributing to 1,663,898 person‐years of follow‐up, during which 395 were diagnosed with IBD. The frequency of any infection at 0 to < 1 and 1 to < 3 years showed a pooled aHR of 1.01 (95% confidence interval [CI] = 0.96–1.07) and 1.00 (95% CI = 0.99–1.01) per additional infection for IBD. Adjusting for infections, any versus no antibiotics in the first year was associated with IBD (pooled aHR = 1.33 [95% CI = 1.01–1.76]). The aHR for additional antibiotic course was 1.17 (95% CI = 0.96–1.44), driven by penicillin (per additional course, aHR = 1.28 [95% CI = 1.02–1.60]). Although antibiotics at 1 to < 3 years did not show an association with IBD or Crohn's disease, non‐penicillin antibiotics were associated with ulcerative colitis (per additional course, aHR = 1.95 [95% CI = 1.38–2.75]).ConclusionEarly‐life antibiotic use was, a significant risk factor for childhood and early adult‐onset IBD, independent of infection frequency.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生命早期感染、抗生素与儿童期和成年早期炎症性肠病的后期发病风险:两个斯堪的纳维亚出生队列的汇总分析
背景儿童时期抗生素的使用与炎症性肠病(IBD)有关,但感染频率的潜在影响仍不确定。方法我们使用了来自 ABIS(瑞典)和 MoBa(挪威)队列的基于人口的数据,这些数据跟踪了儿童从出生(1997-2009 年)到 2021 年的情况。前瞻性收集的问卷调查确定了3岁前的感染频率(任何感染、胃肠道感染和呼吸道感染)和抗生素使用情况(任何抗生素、青霉素和非青霉素)。IBD的诊断需要在国家健康登记簿上有≥2条记录。使用随机效应模型估算并汇总了同组特异性危险比(aHR),并对父母教育程度、吸烟和 IBD 进行了调整。结果共有 103,046 名儿童(11,872 名 ABIS 儿童和 91,174 名 MoBa 儿童)接受了 1,663,898 人年的随访,其中 395 名儿童被诊断出患有 IBD。0至1年和1至3年的任何感染频率显示,IBD每增加1例感染的合并死亡率分别为1.01(95% 置信区间 [CI] = 0.96-1.07)和1.00(95% CI = 0.99-1.01)。对感染进行调整后,第一年使用任何抗生素与未使用抗生素均与 IBD 相关(汇总 aHR = 1.33 [95% CI = 1.01-1.76])。在青霉素的作用下,额外抗生素疗程的 aHR 为 1.17(95% CI = 0.96-1.44)(每个额外疗程,aHR = 1.28 [95% CI = 1.02-1.60])。结论早期使用抗生素是儿童期和成年早期IBD的重要风险因素,与感染频率无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Editorial: Allostatic Load and Inflammatory Bowel Disease. Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply. Issue Information Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing? Authors' Reply
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1